Browsing Tag
Khosla Ventures
12 posts
Is Basis about to rewrite the economics of accounting firms with autonomous AI agents?
Basis raises $100M at a $1.15B valuation as accounting firms deploy autonomous AI agents across tax, audit, and CAS. Find out what changes next.
Can AI-powered MRI automation fix radiology’s staffing crisis? Vista AI raises $29.5m with hospital backing
Vista AI raised $29.5M to expand its automated MRI platform across hospitals. Find out how it's reshaping radiology workflows and staffing today.
What makes HiOctave different from other AI chat platforms—and why investors are betting big
HiOctave secures $15M funding to deliver AI + human customer experience tools to SMBs. Learn how this shapes AI adoption in small business.
Why Ramp’s $22.5bn valuation has investors chasing the future of AI‑driven expense management
Ramp raises $500M at a $22.5B valuation to scale autonomous AI agents for finance. Find out how Ramp Business Corporation is changing workflows today.
Bitwise secures $70m in new funding to expand crypto investment solutions
Bitwise Asset Management, a leading crypto-specialist asset manager overseeing more than $12 billion in client assets, has successfully…
QualityKiosk, DevRev partner to advance AI-driven CX and digital transformation
In a strategic move set to reshape AI-driven business transformation, QualityKiosk Technologies has announced a partnership with DevRev,…
OpenAI raises $6.6bn to push AI boundaries as valuation skyrockets to $157bn
OpenAI has rocked the tech world yet again by raising a jaw-dropping $6.6 billion in fresh funding, launching…
DevRev secures $100.8m in Series A funding, achieves $1.15bn valuation
DevRev, an innovative AI-native platform that integrates customer support and product development, has announced a successful $100.8 million…
Skyflow secures $30m to advance data privacy solutions for AI
In a strategic move to bolster its position in the data privacy sector, Skyflow has successfully raised $30…
Vivodyne lands $38m to transform drug development with lab-grown human organs
Vivodyne, a biotech company focused on developing more effective drugs tested on lab-grown human organs, announced a colossal…